Given that FGFR4 inhibitor treatment can prevent the growth of several types of cancer cells, we further evaluated the effect of FGFR4 inhibition in conjunction with METTL16 inhibition on CCA cell growth. The gene discussed is FGFR4; the disease is cancer.